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Repetitive Transcranial Magnetic Stimulation (rTMS) of the cerebral cortex has been 
previously applied as a non-invasive therapy for neurological conditions due to its 
potential to modify cortical excitability through neuroplasticity. Cerebellar 
stimulation has the potential to modify cortical excitability because of its 
predominantly inhibitory connections with the motor cortex and other cortical areas. 
Previous studies have shown that cerebellar rTMS, including theta burst stimulation 
(TBS) can modulate excitability in the motor cortex, but the findings have been 
variable. The aim of this study was to investigate the effects of 30Hz cerebellar TBS 




Combined TMS and electroencephalography (TMS-EEG) was carried out on 16 
healthy participants, aged 21-30 years. Each subject was studied in three separate 
sessions, in which 30Hz intermittent TBS (iTBS), continuous TBS (cTBS) or sham 
stimulation at stimulus intensity of 80% or 90% of active motor threshold (AMT) was 
applied to the right cerebellar hemisphere. Each session consisted of active and 
resting MEP and TEP recording from the left motor cortex before and after TBS. EEG 
recordings were analysed offline using EEGLAB software and independent 
component analysis (ICA) was used to remove artifacts. TEP were extracted and 
averaged. Mean N100 waveform amplitudes were measured before and after each 
treatment protocol. Post stimulation values for all parameters were compared using 










The TBS protocol at 90% of AMT stimulus intensity produced a significant decrease 
in amplitude of the resting MEP after cTBS compared to sham TBS, F(2,13)= 4.87, 
p=0.035. Cortical silent period (CSP) was increased following iTBS, compared to 
sham, F(2,13)= 4.87, p=0.026. The effects of 80% TBS on MEP were not significant 
The mean N100 amplitude was significantly greater after iTBS than sham TBS using 





The study demonstrated that 30Hz cerebellar cTBS at 90% AMT produced a 
reduction in overall excitability of the contralateral motor cortex, as shown by 
reduced resting MEP amplitude. Although iTBS produced an increase in the CSP and 
the N100 amplitude, both thought to reflect intracortical inhibition, there was no 
significant effect of iTBS on MEP amplitude. As this measure is dependent on the net 
effect of inhibitory and facilitatory networks in the cerebral cortex, it is possible that 
an increase in intracortical inhibition cancelled out the inhibitory effects. These 
findings provide further evidence that cortical excitability can be modulated through 
cerebellar TBS. Cerebellar TBS has potential as a therapeutic modality for a number 
of neurological conditions where there is abnormal cortical excitability, including 
epilepsy, dystonia and Parkinson’s disease. Future investigation of its effects is 









Transcranial magnetic stimulation (TMS) is a non-invasive method of brain 
stimulation, which involves the induction of a painless electrical current in the brain 
by means of a coil applied to the surface of the scalp. It has been used in neurological 
diagnosis and more recently as a form of treatment. 
 
The motivation of this study was to investigate theta burst stimulation (TBS), a 
particular type of TMS applied to the cerebellum, as a potential treatment for 
epilepsy. 25-30% of patients with epilepsy are resistant to treatment with medication 
and alternative therapies are few. Other forms of brain stimulation have been trialed 
in the past, but with variable success. 
 
The cerebello-thalamo-cortical pathway has been shown to have inhibitory effects on 
the cerebral cortex and therefore cerebellar stimulation would appear to be a logical 
approach to epilepsy treatment. But before proceeding with clinical trials, the effects 
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There are a number of neurological diseases that are refractive to current treatment 
regimes. The motivation of this study was to explore an alterative therapy that has 
been around for a number of years, to investigate whether using this approach could 
highlight new evidence that could be applied as a potential treatment for these 
conditions. 
 
Transcranial Magnetic Stimulation (TMS) is a non-invasive technique that is used as 
a diagnostic tool for a number of neurological conditions and repetitive TMS (rTMS) 
has been used as a form of treatment (Curra et al., 2002; Kobayashi & Pascual-Leone, 
2003). The central nervous system (CNS) is reliant on the balance of the excitatory 
and inhibitory circuits. Each neuron and synapse forms a complex system that 
mediates all aspects of interneuronal communication. Every motor and non-motor 
process is highly specialised and dependent on these neural circuits.  
 
Neurotransmitters and cellular receptors interact to facilitate and determine the 
balance between these excitatory and inhibitory networks. This process is controlled 
by ion channels controlling the flow of ions or by intracellular connections through 
secondary mechanisms. Inhibition is primarily mediated by the action of γ-
aminobutyric acid (GABA) on the GABA-A and GABA-B receptors and excitation is 
facilitated by glutamate action on N-methyl-D-aspartate receptor (NMDA) and non-
NMDA receptors (Masson, Sagne, Hamon, & Mestikawy, 1999). 
 
 Disruption in these circuits can result in altered excitability as seen in a number of 
neurological conditions, including epilepsy, stroke, amyotrophic lateral sclerosis 
(ALS), dystonia, Huntington disease, Parkinsonian disorders, cerebellar diseases, and 
tremor. Drug therapy has been applied to treat this imbalance in a number of 
conditions. Antiepileptic drugs (AED) have been administered to treat the changes 
associated with cortical excitability in epilepsy, although there are a number of 
patients who are refractive to this approach, which has initiated the search for 




Recently there has been increased interest in the application of rTMS as a therapeutic 
treatment for refractive epilepsy. Clinically, rTMS has demonstrated promising results 
in a few studies, although the clinical efficacy to treat the altered cortical excitability 
in epilepsy has yet to be determined (Brighina, Daniele, Piazza, Giglia, & Fierro, 
2006; Fregni et al., 2006).   
 
1.1. TMS as a method for assessing cortical excitability 
The use of TMS is based on the principle of electromagnetic induction. This is 
produced by passing a high electrical current through a coil of wire placed against the 
scalp, to produce a small electrical current in the underlying cerebral cortex, and is 
non invasive and pain free (Hallett, 2000) (Figure 1.1).  
 
There are three main types of TMS: 
 
Single pulse TMS involves single pulses, usually applied to the motor cortex to 
activate the corticospinal tract and elicit a motor evoked potential (MEP), recorded 
over muscle groups contralateral to the site of stimulation. MEP are used in diagnosis; 
to measure conduction times in the CNS, especially in diagnosis of multiple sclerosis 
(Sahota et al., 2005; Rossini, 1998). They are also useful to assess cortical 
excitability: the amplitude of the motor response reflects the net effect of the 
excitatory and inhibitory networks in the cortex. When a single pulse is administered 
to the motor cortex, the lowest TMS stimulus intensity required to produce this 
response is referred to as the motor threshold (MT). This measure has been also 
described as a reflection of excitability of the corticospinal neurons and those 
interneurons that synapse on the corticospinal neurons of the motor cortex. MEP can 
be recorded while the muscles are at rest (resting MEP) or while contracting (active 
MEP). Following active MEP there is a brief period of muscle silence (suppression of 
the electromyogram), which is referred to as the cortical silent period (CSP). The CSP 





Paired pulse TMS is another useful technique to examine the cortical 
excitability and inhibitory circuits of the motor cortex. This type of stimulation 
involves applying a sub threshold conditioning stimulus (CS), which is then followed 
by a supra-threshold test stimulus (TS). The inter-stimulus interval (ISI) is of 
importance, as it determines the level of inhibition or facilitation. MEP amplitude is 
reduced if the CS is 1-4ms before the TS, and this phenomenon is referred to as short 
interval intracortical inhibition (SICI). Long interval intracortical inhibition (LICI) is  
demonstrated by a long ISI (50-200ms), which causes a reduction in the MEP 
amplitude. If the ISI is between 7 and 20ms, the MEP amplitude is increased, also 
known as intracortical facilitation (ICF). It has been proposed that the excitatory 
postsynaptic potentials (EPSPs) that transmit glutamate are where this facilitation 
originates and in comparison inhibition is thought to be due to the action GABA as a 
neurotransmitter (Kobayashi & Pascual-Leone, 2003).  
 
The third type of TMS is repetitive TMS, which is proposed as a form of 
therapy and has been shown to modify cortical excitability in a number of studies 
(Fierro et al., 2007; Helfrich et al., 2012). The application of this therapy will be 
discussed in a later section. 
 
The interaction between TMS and intracortical inhibition has been explored in a 
number of studies, and there is evidence that the CSP is affected by the intensity of 
TMS and reflects intracortical inhibition (ICI). There is evidence that the CSP 
shortened with SICI, pharmacological research has suggested that it is mediate by 
GABA-A (Kojima et al., 2013). Administration of GABA-B receptor agonists such as 
baclofen increased CSP and LICI. These studies have contributed to a better 





TMS has been used to investigate changes in MEP, CSP, ICF, SICI and LICI in a 
number of neurological conditions. For example, TMS has been used in dystonia, 
which is a movement disorder, the precise mechanism of which is unknown. TMS has 
been used to show that patients with dystonia involving the hand and facial muscles 
have a shortened CSP (Filipovic, Rothwell, & Bhatia, 2010). These findings are 
consistent with evidence that suggests there is a decrease in GABA-ergic inhibition in 
patients with dystonia (Siebner, 1999). The introduction of TMS and paired pulse 






Figure 1.1. Induced currents in the brain by the TMS coil. A demonstration of the 
induced currents in the brain and the direction of current flow following the 
application of the magnetic coil (Diagram by A Harrington and D Kingma, 2014). 
Wire Coil 
Magnetic Field Lines 







Figure 1.2. MEP following TMS over the left motor cortex of a healthy control. The 
arrows indicate the MEP and the CSP. The measurement of the CSP onset and offset 
times can vary between investigators; the onset in some studies is recorded from the 
beginning of the MEP onset, TMS onset or the appearance of the TMS artifact. 
Similarly differences occur with the offset measurement (Rabago, Lancaster, 
Narayana, Zhang, & Fox, 2009). For this study we measured CSP as the time interval 
from the stimulus to the reappearance of the EMG activity.   
 
1.2. TMS-EEG as a method for assessing cortical excitability 
Assessing cortical excitability through MEP is an effective tool although this method 
is limited to the motor cortex. When investigating cortical excitability in neurological 
conditions there is a need to examine other areas of the cortex where the disease may 
originate or spread. In order to assess cortical excitability in other parts of the brain, 
TMS combined with EEG (TMS-EEG) has demonstrated promise (Fitzgerald, 2010). 
TMS-evoked potentials (TEP) have been used as an index of cortical excitability in a 






Several components have been demonstrated using single-pulse TMS in the motor 
cortex; for example the N15 (EEG component that is a negative peak at 
approximately 15ms post-stimulus), P30 (EEG component that is positive, 30ms post-
stimulus) and others such as N45, P60, N100, and P200 (Ilmoniemi & Kicic, 2010). 
These components can vary between individual subjects depending on whether they 
are patients or healthy controls and the experimental setup (Kicic, 2009). It has been 
demonstrated that the N100 component of the TEP is a reflection of cortical 
inhibition. The N100 is a negative trough that occurs approximately 100msec 
following the TMS stimulus (Figure 1.3) (Ilmoniemi & Kicic, 2010).  
 
The amplitude of N100 and the CSP duration displayed a significant correlation, 
supporting previous evidence that the N100 relates to inhibition (Kimiskidis, 
Kugiumtzis, Papagiannopoulos, & Vlaikidis, 2013). As previously described there is a 
relationship between CSP and LICI and intracortical inhibition (Tremblay et al., 
2013). Studies have shown a relationship between that the N100 component and LICI, 
and it has been suggested that is mediated by GABA-B inhibition. CSP measure is 
limited to surface EMG where as N100 is associated with activation of inhibitory 
cortical circuits (Rogasch, Daskalakis, & Fitzgerald, 2013). 
 
A previous study investigated TMS-evoked EEG potentials in attention deficit 
hyperactivity disorder (ADHD) children to identify a marker that could be applied to 
real-time monitoring of the rTMS effect. In this particular trial 1Hz rTMS was applied 
to the primary motor cortex of children with ADHD and the TMS evoked N100 
potential was studied. Following 1Hz rTMS the N100 potential was reduced and there 
was no reduction after sham stimulation. The results also showed that the N100 
potential was a more sensitive marker than rTMS-induced changes in MEP amplitude. 
The authors of the study suggested that based on these findings the N100 component 






In contrast, a recent study has investigated the effects of rTMS on the TEP in the 
primary motor cortex of healthy controls. Following 1Hz there was a significant 
increase in the P60 and N100 components of the TEP. These results are in line with 
previous studies that have also demonstrated that there is a relationship between the 
N100 component and cortical inhibition, therefore making it a reliable marker 
(Bonnard, 2009; Nikulin, Kicic, Kahkonen, & Ilmoniemi, 2003) (Casula et al., 2014).  
 
EEG has the ability to measure the effects of TMS in the brain (Blinowska, 2006). 
The use of EEG combined with TMS has excellent sensitivity in non-motor areas with 
increased spatiotemporal specificity, which allows the study of interhemispheric 
connections as well as cortical excitability (Komssi, Kahkonen, & Ilmoniemi, 2004) 
 
The reproducibility of TEP was highlighted in the study conducted by Lioumis and 
colleagues (2009). TMS was applied at varying intensities over the participants’ left 
motor and prefrontal cortices, and repeated at one-week intervals. The authors 
concluded that responses for both left and prefrontal cortex cortical stimulation areas 
were highly reproducible, and a reliable means of investigating cortical excitability 
(Lioumis, Kicic, Savolainen, Makela, & Kahkonen, 2009). 
 
TMS-EEG has limitations. It is designed to record activity from the cerebral cortex 
but includes unwanted electrical activity known as artifact. Artifact can arise from 
within the patient (physiologic) such as eye blink or from an external source 
(extraphysiologic), which can come from equipment such as the TMS coil. The main 
artifact associated with combining TMS with EEG is due to the large electromagnetic 
pulses; TMS induces a large artifact within the EEG recording. There are ways to 
limit the artifacts when recording, including careful preparation of the electrodes to 






Independent component analysis (ICA) has been used to remove artifacts from the 
EEG recording. ICA is capable of extracting independent sources from a mixed 
signal.  It can solve the “cocktail party problem” where the speech of a single speaker 
needs to be separated from the background noise and is very effective in separating 
EEG signals and artifacts of different origin (Hyvarinen & Oja, 2000) (Figure 1.3).  
 
Recent literature has been published to support the importance of removing artifacts 
using ICA. This study additional highlights the challenges faced when coming TMS-
EGG when investigating cortical networks. The study applied ICA as a tool to remove 
these artifacts in order to assess TMS evoked changes in the dorsolateral prefrontal 
cortex (DLPFC). The results demonstrated that once the artifacts where removed 
using ICA the TEPs measure such as the N100, P60 could be identified. Overall, this 
provides evidence that ICA is a fundamental analysis tool that enables a contaminated 
TMS-EEG recording to be extracted for components without severely impacting the 












Figure 1.3 TMS-evoked potential (TEP) before and after ICA. The arrow indicates 
the N100 component. The top image displays the TEP before ICA, the image shows 
the large TMS artifact and the tail of the artifact hides the components. The bottom 
image demonstrates the TEP following ICA; it has removed a significant amount of 
the artifact, making it simpler to see the TMS components required for analysis.   
 
 
1.3. Abnormal cortical excitability in disease 
Epilepsy is a common neurological condition, defined as the occurrence of recurrent 
seizures. Seizures are divided into two main types: generalised and partial seizures. 
Generalised seizures are characterised electroencephalographically as having onset of 
paroxysmal activity over the entire cortex, while partial (also referred to as 
local/focal) seizures originate in a localised part of the cortex. Epilepsy is a complex 






imbalance between the excitatory and inhibitory networks in the CNS (Valentin et al., 
2008). There are a number of processes such as transmitter uptake, change in receptor 
function, extracellular ion homeostasis that can be altered, resulting in the imbalances 
which result in epilepsy (Badawy, Freestone, Lai, & Cook, 2012).  
 
It has been proposed that epilepsy is characterized by a net increase in cortical 
excitability. A key point to understand about the epileptic brain is that it exists in a 
number of states. In a healthy individual there are a number of factors that influence 
the CNS to function normally. Neurons and the neural circuits mediate each and every 
action, behavior, emotion and response and are dependent on healthy excitatory and 
inhibitory circuits. Patients with epilepsy have ever changing states of cortical 
excitability (Badawy, Freestone, Lai, & Cook, 2012). The spontaneity of seizure 
occurrence is thought to occur because of the shift between the interictal (period 
between seizures) and ictal (state of seizure) states.  
 
Some seizure types can be easily identified by the anatomy that they arise from, such 
as temporal lobe seizures, although studies have identified the complexity of the 
mechanisms associated with this condition. Seizure initiation has been investigated in 
numerous animal and human studies, which suggest that the epileptogenic foci (which 
refers to the alteration of normal neuronal network into a hyperexcitable state) play a 
role in loss of inhibition (Depaulis, 1994). This results in the neighboring neurons 
being excited, which facilitates spread of the seizure activity. The imbalance between 
the excitatory and inhibitory networks leads to the hyperexcitable states reported in 
the cortical motor areas in drug resistant patients. Hyperexcitable states occur when 
there is an increase in synaptic neurotransmission or a decrease in inhibitory 
neurotransmission (Lopes da Silva et al., 2003; Badawy et al., 2012).  
 
The MT has been investigated in patients with generalised and focal epilepsy. There 
is evidence that patients with partial epilepsy on AED, showed an increase in the MT 
when compared to the controls (Tataroglu, Ozkiziltan, & Baklan, 2004). This increase 
was also demonstrated in patients with juvenile myoclonic epilepsy (JME), who were 
also on AED (Akgun et al., 2009).  
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In some subsets of patients with JME there was a decrease in MT (Brigo et al., 2012; 
Manganotti, Bongiovanni, Zanette, & Fiaschi, 2000). Additional studies have 
investigated patients with untreated generalised epilepsy and showed that their MT 
were lowered when compared to control subjects (Reutens., 1992,1993) (Table1.1). 
Cortical MT have been described as a reflection of the excitatory and inhibitory 
activity of the motor cortex. If individuals with epilepsy have an increase in cortical 
excitability, it would be expected that their MT be decreased suggesting a reduction in 
intracortical inhibition. There are a number of discrepancies between these studies as 
shown in Table 1.1. One explanation is that in the studies where there was an increase 
in MT, the patients were on AED. AED may act to increase the pathological low MT 
that would be expected in epileptic patients. The AED act to suppress seizures by 
modulating membrane excitability or by modifying excitability or inhibitory 
synapses. Another explanation is that each of these studies was using different TMS 
protocols that could have led to the variability in the results.    
 
The CSP is another measure that is of interest because it has been described as a 
measure of inhibition. This measure has been explored in patients with both types of 
epilepsy and the results are variable; some studies demonstrated that the CSP was 
prolonged and others suggested that it was shortened in focal epilepsy on the affected 
side (Table 1.1). Findings with regard to ICI, ICF, SICI and LICI are also shown in 
Table 1.1. There is evidence that indicates that patients with JME have a decrease in 
early ICI in both hemispheres compared to controls and there was no difference in 
ICF (Manganotti et al., 2000), whereas other studies have demonstrated no change in 
this measure.  
 
Similarly to the MT there is evidence to suggest that AEDs can affect ICI, although 
the effect does not appear to be as great. ICI and LICI have been identified as 
measures of intracortical inhibition and it has been suggested that they reflect the 




Studies have demonstrated a reduction in LICI in patients with both generalised and 
focal epilepsy, irrespective of drug therapy (Badawy, Curatolo, Newton, Berkovic, & 
Macdonell, 2006; Badawy, Curatolo, Newton, Berkovic, & Macdonell, 2007; 
Badawy, Macdonell, Berkovic, Newton, & Jackson, 2010).  
 
 
A reduced LICI is expected as it indicates a reduction in inhibition in these epileptic 
patients. Overall the findings continue to add to the understanding of how complex 
epilepsy is and display that there are a number of challenges faced when targeting 
abnormal cortical excitability.  
 
Imbalance between the excitatory and inhibitory circuits has also been proposed as a 
possible mechanism in other neurological conditions. Amyotrophic lateral sclerosis 
(ALS, also referred to as a motor neuron disease) is characterised by rapidly 
progressive muscle atrophy. The mechanism of motor neuron degeneration remains 
elusive, although altered cortical excitability has also been proposed as a cause 
(Bruijn et al., 1997) MEP findings have been variable. It has been reported that 
patients with ALS have a reduced MT and CSP, which supports the cortical 
hyperexcitability theory (Caramia et al., 1991; Triggs et al., 1999). Studies also 
showed a decreased SICI in ALS, which has been proposed as the cause of 
degeneration in the intracortical inhibitory circuits (Vucic, Cheah, & Kiernan, 2009) 
 
A number of neurological conditions involve abnormal cortical excitability, which has 
become an increasingly popular concept that is beginning to extend the understanding 
of these complex conditions and suggests that the symptoms could be treated with the 

















• Decreased RMT in 
patients with JME (Brigo 
et al., 2012) 
• Mean MT lower in 
patients with IGE 
compared to controls 
(Macdonell, 2001). 
• Lower in untreated 
patients when compared 
to control (Reutens & 
Berkovic, 1992; Reutens, 
Berkovic, Macdonell, & 
Bladin, 1993). 
• RMT higher in patients 
with JME (Akgun et al., 
2009) 
• Decrease in MT in JME 
patients without treatment 
(Manganotti et al., 2000). 
 
• Increased MT in 
patients with 
partial epilepsy 
(all subjects were 
on AEDs) when 
compared to 
controls 
(Tataroglu et al., 
2004). 
• RMT increased in 
two patients with 
focal epilepsy in 
the group overall 









Cortical Silent Period 
 
 
• Increased at all 
stimulus intensities in 
patients with IGE 
(Macdonell, 2001) 
• Decrease in MT in 
JME patients without 
treatment (Manganotti 
et al., 2000). 
• Primary generalised 
patients had prolonged 
SP irrespective of the 
number of drugs 
administered 
(Tataroglu et al., 2004) 
• In patients with 
myoclonic epilepsy 
there was a prolonged 
CSP; duration of CSP 
was not altered with 
drugs (Tataroglu et al., 
2004). 
• Longer CSP in JME 
(Akgun et al., 2009) 
• Patients with untreated 
IGE CSP was normal 
(Badawy et al., 2007; 
Klimpe et al., 2009) 
 
 





• In patients with 
focal motor epilepsy 





• Patients with focal 
epilepsy outside the 












epilepsy had no 
changes in either 
hemisphere in SP 
when compared to 
controls (Badawy et 
al., 2007; Klimpe, 
Behrang-Nia, Bott, 














• Decrease or even 
absence in early ICI 
in patients with JME 
(Manganotti et al., 
2000). 
• No difference in ICF 
in JME (Manganotti 
et al., 2000). 
•  
• Untreated IGE and 
treated progressive 
myoclonic epilepsy 
showed an overall 
reduction in LICI 
(Badawy et al., 2007; 
Badawy et al., 2010) 
 
• Two treated patients 
had an increase in 
SICI (Caramia et al., 
1996). 
 
• Decrease ICF in the 
abnormal hemisphere 
of patients, normal 
ICI (Werhahn, 2000). 
 
• In the normal side 
decrease in ICI and 
only a slight decrease 
in ICF (Werhahn, 
2000). 
• In patients with 
untreated focal 
epilepsy the affected 
hemisphere had a 
decrease in LICI 
(Badawy et al., 2006; 
Badawy et al., 2007; 




Table 1.1.  Overview of intracortical TMS findings in epileptic patients. Each 
section summarises studies for each TMS measure, across the two types of epilepsy 
Abbreviations: RMT = resting motor threshold; MT = motor threshold; CSP = cortical 
silent period; JME = juvenile myoclonic epilepsy; IGE = idiopathic generalized 
epilepsy; AEDs = anti epileptic drugs; ICI = intracortical inhibition; ICF = 
intracortical facilitation; SICI = short-interval intracortical inhibition; LICI = long 
term intracortical inhibition; TMS = Transcranial magnetic stimulation; rTMS = 
repetitive Transcranial magnetic stimulation; EEG = electroencephalography  
 
1.4. TMS as a treatment for disease 
The brain has a remarkable ability to be ‘plastic’- to develop and adapt. Studies have 
explored the role of synaptic plasticity in neurological conditions and the potential for 
modulation by rTMS. Long-term potentiation (LTP) and long term depression (LTD) 





have significance in synaptic plasticity, and have importance in clinical applications. 
LTP is defined as the long lasting enhancement of synaptic transmission between two 
neurons, where as LTD is the reduction in efficacy of the neuronal synapses (Bliss & 
Cook, 2011; Badawy et al., 2006). 
 
The modulation of neuronal synapses by non-invasive stimulation is an emerging 
therapy and it has been previously applied successfully as a therapy for 
neuropsychiatric conditions. rTMS has been used as a neuromodulation technique. 
This is the application of trains of magnetic stimuli with the aim of modifying cortical 
plasticity rTMS pulses when applied to the brain are given at constant intensity, but 
the frequency of the stimulus can vary between 1-20s or more (Bliss & Cook, 2011). 
The frequency of the stimuli determines the level of excitation or inhibition that 
occurs in the neuronal circuitry within the cortex. It has been shown that a frequency 
greater than 5Hz (high frequency TMS) induces an excitatory effect whereas 1Hz or 
less (low frequency) induces an inhibitory effect (Kobayashi & Pascual-Leone, 2003).  
 
rTMS was first reported as a successful treatment in depression. Patients that suffer 
from depression have a reduced level of activity in the left dorsolateral prefrontal 
cortex (DLPFC). Neuroimaging studies have shown that in the left DLPFC there is 
hypometabolism in depressed patients (Aleman, 2013; Fitzgerald et al., 2009). 
Therefore excitatory rTMS using a stimulation frequency of 5Hz or greater has been 
investigated as therapeutic approach in this region.  Low frequency rTMS has been 
used to treat the right DLPFC on the basis that there may be an imbalance between 
the two prefrontal regions. The clinical trial on treatment-resistant depression supports 
that rTMS has antidepressant effect which was observed as a significant reduction in 
the Montgomery-Asberg Depression Rating Scale over the course of the trial. rTMS 





Subsequently a different rTMS protocol known as TBS was introduced. It requires 
lower intensity and less stimulation time to induce long lasting effects that can 
modulate cortical excitability in the motor cortex. Previous animal studies had 
demonstrated that, when applied over the motor cortex, TBS induced LTP (Hess & 
Donoghue, 1996).  
 
Huang and co workers (2005) were the first to apply different patterns of TBS to the 
motor cortex to investigate neuroplasticity (Huang, Edwards, Rounis, Bhatia, & 
Rothwell, 2005).  
 
There are two main TBS protocols: 
  Intermittent TBS (iTBS) has been shown to have a facilitatory effect, resulting 
in a transient increase in the MEP as well as an increase in short intracortical 
inhibition (SICI) (Huang, Edwards, Rounis, Bhatia, & Rothwell, 2005). iTBS consists 
of theta frequency (usually 5Hz) bursts of 3 TMS stimuli (usually at 50Hz) in 2 s 
trains occurring every 10s.  
In contrast, continuous TBS (cTBS) has been shown to decrease the SICI and 
intracortical facilitation (ICF) with suppression of the MEP amplitude (Huang et al., 
2005). cTBS involves one continuous train of theta frequency bursts of 3 stimuli at 
50Hz.  In both iTBS and cTBS, 600 stimuli are usually applied (Huang et al., 2005; 
Koch et al., 2008). 
 
Preliminary results suggest that TBS can be applied to neurological conditions such as 
Parkinson’s disease and chronic stroke to alter cortical excitability (Carrillo et al., 
2013; Koch et al., 2014). TBS displays a promising advantage over standard rTMS 
protocols.  
 
The use of lower stimulus frequency, such as 30Hz has an advantage compared to 
50Hz TBS because of its ability to be delivered at higher stimulation intensity, using 
stimulators with limited capability. Only a small number of studies have explored the 
application of 30Hz stimulation and its ability to alter cortical excitability in motor 
and non-motor regions in the cortex (Nyffeler, 2008; Wu, Shahana, Huddleston, & 
Gilbert, 2012). 




Wu and colleagues (2012) investigated the motor cortex in 18 healthy adults to 
explore the effects of iTBS and cTBS at 30Hz frequency. The results showed an 
increase following iTBS in MEP amplitude whereas cTBS had the opposite effect. 
Overall the safety of 30Hz TBS was consistent with other TBS studies, and the 
direction of change observed were similar to what other studies had shown with 50Hz 
stimulation (Wu, Shahana, Huddleston, & Gilbert, 2012).  
 
Previously we studied the effects of 1Hz rTMS and 30Hz iTBS on the motor cortex of 
healthy individuals and showed that there was a reduction in the N100 component 
with iTBS. This has provided evidence that there is potential for 30Hz TBS to 
modulate the cortical excitability, although other avenues need to be explored to 
determine the optimal stimulation area and parameter (unpublished).  
 
Low frequency rTMS and cTBS have been shown to reduce the cortical excitability of 
the motor cortex (Chen et al., 1997). This particular effect of rTMS has been explored 
in a number of studies to inhibit the epileptic activity. The clinical efficacy of rTMS 
in epilepsy has been under debate due to the inconsistency in the results. Tergau and 
co-workers investigated the application of 0.33Hz rTMS in a small sample size of 
nine patients with focal intractable epilepsy. They demonstrated a reduction in the 
number of seizures and the severity of symptoms recorded in eight of the patients 
(Tergau, Naumann, Paulus, & Steinhoff, 1999). Additionally Cantello and colleagues 
(2007) studied a larger sample of drug resistant epileptic patients using the same low 
frequency stimulus of 0.3Hz in a 5-day cycle, which was applied at the resting motor 
threshold (RMT) of each patient. The results were variable and only one third of the 
patients displayed a decrease in the interictal EEG abnormalities. Even though these 
results were not significant there was evidence to suggest that the rTMS was having 
an effect and was a safe method (Cantello et al., 2007). 
 
Further studies have explored low frequency rTMS in the patients with refractive 
epilepsy and abnormalities of cortical development. The stimulation parameter 
frequency of 0.9Hz was reported to have a tendency to reduce the number of seizures, 
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 but this was not statistically significant (Kinoshita et al., 2005). Additional research 
has demonstrated that five consecutive low frequency rTMS sessions were able to 
cause a significant decrease in the number of seizures in these refractive patients. 
Interestingly, the cortical inhibition following the rTMS in these patients lasted for a 
duration of two months (Fregni et al., 2006). 
 
 
Another study investigated epileptic patients with partial seizures to explore whether 
rTMS could reduce epileptic discharges (ED) in patients that had epilepsy controlled 
by AEDs and patients that were refractive to drug therapy. EEG was used to examine 
the TMS effect. The stimulation frequency varied between 0.3 and 15Hz and was 
applied in trains of 1-10 biphasic stimuli. The study explored the effect of rTMS 
treatment on the duration of the epileptic discharges (ED), and the duration of the ED 
was reduced following rTMS. Overall the study demonstrated that with frontal lobe 
epilepsy, ED in patients could be modulated using TMS. The study highlighted that 
the ability of rTMS to modulate the ED was through superficial stimulation and that 
patients with deep epileptogenic foci in areas such as the temporal lobe, may not be 
suitable for rTMS treatment and further research was required to enable a suitable 
‘deeper’ stimulation paradigm (Kimiskidis et al., 2013). 
 
The relationship between 1Hz rTMS and the N100 component as been recently 
investigated by Casula and co workers (2014) who applied 1Hz rTMS to the primary 
motor cortex of healthy controls. Following rTMS there was an increase in the P60 
and N100 component. Overall this study has confirmed the reliability to the N100 in 
TEP as an indicator of cortical inhibition (Casula et al., 2014). 
 
Although a number of these studies have demonstrated the potential for rTMS, 
including TBS to induce changes in the cortical excitability of patients with refractive 
epilepsy, the ability of rTMS to reduce seizures is variable, depending on the 
stimulation parameters (Cantello et al., 2007). These results warrant further 
investigation because, even though the effects of low frequency rTMS were variable, 
other methods such as TBS could have greater effect and require less stimulation time 




1.5. Other therapeutic forms of brain stimulation 
Alongside TMS there are other forms of brain stimulation that have been used as a 
treatment for neurological conditions. There are a number of studies that have 
provided evidence that the motor cortex excitability can be modulated by transcranial 
direct current stimulation (tDCS). tDCS involves placing electrodes on the scalp over 
the brain region of interest, and a constant low direct current is passed through the 
electrodes causing an intracerebral flow of current, which either decreases or 
increases neuronal excitability. There are three different types of tDCS, anodal 
(positive stimulation), which increases neuronal excitability, cathodal (negative 
stimulation), which decreases neuronal excitability and sham, which is designed to 
mimic the tDCS (Kuo, Paulus, & Nitsche, 2014). 
 
Deep brain stimulation (DBS) is another stimulation method that has provided 
therapeutic benefit to patients with Parkinson disease, dystonia, and essential tremor. 
DBS involves surgically implanting electrodes in deep structures such as the globus 
pallidus and subthalamic nucleus.  A brain ‘pacemaker’, implanted in the chest wall is 
connected to the electrodes that interfere with the neural activity at the specified brain 
site. Even though DBS is applied in some cases, the procedure is invasive, which 
continues to highlight the demand for alternative therapies such as TMS which is non 
invasive.  DBS however is now part of standard treatment for Parkinson’s disease, 
whereas the use of rTMS in neurological disorders remains experimental (Limousin & 
Martinez-Torres, 2008). 
 
1.6. Cerebellar stimulation as a therapy 
The application of TMS to the cerebral cortex has been highlighted in previous 
studies as an effective way to modulate cortical excitability. For a number of 
neurological conditions such as epilepsy, the source of the problem may be outside 
the motor cortex or involve extensive portions of the cerebral cortex. The cerebellum 
has extensive connections with the cerebral cortex through direct and indirect 
pathways through which cerebellar stimulation could potentially modulate cortical 
excitability in a variety of cortical areas.  
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Previously the cerebellum was described as simply a motor structure, because damage 
to it resulted in impaired motor function (Holmes, 1917, 1939). Its primary motor 
function is to modify the cortical output to the descending motor pathway to enable 
the movements to be accurately executed and adapted. The cerebellum is essential for 
producing postural adjustment to stabilise and organise balance, fine movement 
coordination, equilibrium and muscle tone. However the cerebellum has extensive 
involvement in non-motor functions as well (Strick, Dum, & Fiez, 2009).  
The ability of the cerebellum to modulate non-motor regions has been demonstrated 
in a number of studies (Strick, Dum, & Fiez, 2009) (Kelly, 2003; Schmahmann, 
1996). It is remarkable that the cerebellum can contribute to such a diverse range of 
behavior from the execution of motor control to learning, language, emotion, working 
memory and pain. The cerebellum has a significant number of output projections to 
these non-motor regions including the pre frontal cortex and the posterior parietal 
cortex.  
The cerebellum consists of two symmetrical hemispheres separated by a midline 
structure, the vermis. The cerebellar cortex contains almost all the neurons in this 
structure, and the deep cerebellar nuclei (DCN) constitute the main output component 
of the cerebellum. There are a number of nuclei that comprise the DCN. The dentate 
nucleus is the largest of these, and receives input from the lateral cerebellar 
hemisphere (Voogd, 1998). 
The cerebellar cortex contains three main layers of cells. The inner layer of granule 
cells receives input from the mossy fibers and projects to the middle layer of Purkinje 
cells. The Purkinje cell layer is the only layer of the cerebellar cortex that has 
inhibitory projections to the dentate nucleus. The outer layer (molecular layer) 
contains the dendrites from the Purkinje cells and the axons from the granule cells 




Figure 1.4. Diagrammatic representation of cerebellar cortical structure. A. 
Midsagittal cross-section of the human cerebellum. B. Cut away section of an 
individual cerebellar cortical lobule, which demonstrates the microstructure 
organization of the cerebellar cortex. The cerebellar cortex has three cellular layers 
and the positioning of the cells and their input and output are illustrated here 
(Diagram by A. Harrington, 2014).  
The two main types of afferent fibers are mossy fibers and parallel fibers, which 
receive input from other parts of the CNS. Mossy fibers are extensively positioned 
throughout the cerebellar cortex and have excitatory synapses on the Purkinje cells. 
The cerebello-thalamo-cortical pathway is of particular importance because of its 
potential to modulate the motor cortex through stimulation of the cerebellum. This 
pathway has been extensively investigated in a number of stimulation studies to 
establish an understanding of the relationship the cerebellum has with non-motor and 
motor regions in the cerebral cortex(Fierro et al., 2007; Koch et al., 2008; Oliveri, 
Koch, Torriero, & Caltagirone, 2005).          
Molecular layer 





















The Purkinje cell axons project to the DCN and have inhibitory synapses on cells in 
the DCN. The efferent pathway from the dentate nucleus exerts an excitatory effect 
on the ventrolateral thalamus. The ventrolateral nucleus has a number of efferent 
pathways to the motor cortex, which terminate at both excitatory and inhibitory 
neurons. The cerebellum has the potential to modulate motor function via this 
pathway (Figure 1.5).  
 
Figure 1.5. Diagrammatic representation of the dentato-thalamo-cortical pathway. 
The red lines indicate the pathway from the dentate nucleus of the cerebellum to the 
motor cortex, through the ventrolateral nucleus of the thalamus (Diagram by 
A.Harrington, 2014). 
A number of animal studies have explored the excitatory and inhibitory cerebellar 
projections.  Activation of non-pyramidal and pyramidal neurons in the motor cortex 
was shown following the stimulation of the cerebellar structures such as the DCN in 
the cat model (Noda & Yamamoto, 1984). Further studies explored the 














microstimulation of the cerebellar nuclei of a conscious monkey; the results 
highlighted a pattern of both facilitation and inhibition in the motor cortex (Holderfer, 
2000). These animal studies have demonstrated that there is connectivity between the 
cerebellum and areas of the cortex. This has provided a basis for exploration of 
cerebellar connectivity in human studies.  
The first study to demonstrate the reduction in motor cortex cortical excitability 
following single pulse stimulation of the cerebellum was by Ugawa and colleagues 
(1995).  The study investigated the effects of the cerebello-thalamo-cortical pathway 
on the motor cortex by applying a conditioning stimulus (CS) (either electrical or 
magnetic stimulation) to the cerebellum followed by a test stimulus (TS) to the motor 
cortex. There was suppression of MEP evoked by the TMS, which is believed to be 
due to an activation of the Purkinje cells, which resulted inhibition of cells in the 
dentate nucleus and thus reduced tonic cerebral cortical facilitation via the dentato-
thalamic-cortical pathway. This inhibitory process has also been referred to as 
cerebellar inhibition (CBI) (Ugawa et al.,1995). Under normal conditions there 
appears to be a tonic excitatory activity in the dentato-thalamo-cortical pathway, 
which is interrupted by cerebellar stimulation, despite the presence of both excitatory 
and inhibitory fibers demonstrated in animal studies. 
The effects of cerebellar tDCS on the primary motor cortex have been explored by 
Galea and colleagues (2009). This study investigated the CBI that is mediated by the 
dentate-thalamo-cortical connections. tDCS was applied to the right hemisphere of the 
cerebellum to assess the changes in the motor cortex, CBI and the brainstem. The 
different stimulation groups were anodal, cathodal and sham. There was a decrease in 
the CBI following cathodal tDCS whereas the opposite effect was observed following 
anodal stimulation.  The cathodal decrease of the CBI was dependent on stimulation 
intensity and lasted up to 30 minutes. Overall the study demonstrated the effect of 
cerebellar tDCS on the corticospinal excitability and its potential for treating patients 
with motor and cerebellar dysfunction (Galea, Jayaram, Ajagbe, & Celnik, 2009). 
Another study that investigated the circuitry between the cerebellum and the motor 





The experiments explored the effect of cerebellar stimulation on the intracortical 
networks as measured by paired pulse stimulation of the motor cortex. Increasing the 
TS intensity led to an increase in SICI and a decrease in all other measures. In the 
presence of CBI, SICI was reduced whereas ICF increased. Finally, there was a 
decrease in CBI and LICI when there was an increase in the TS intensity, suggesting 
that there are a number of similarities between these two measures. Even though both 
CBI and LICI appear at low intensities to inhibit the same neurons, their duration of 
activation appear to be mediated by different mechanisms (Daskalakis et al., 2004). 
The overall findings were variable, suggesting that there were both excitatory and 
inhibitory changes that occurred in the motor cortex following the stimulation of the 
cerebellum, in keeping with animal studies (Holderfer, 2000; Noda & Yamamoto, 
1984).  
rTMS has been applied to the cerebellum in healthy controls, and studies have 
demonstrated that the application of rTMS can produce long lasting modulation of the 
corticospinal excitability (Minks, 2010). Low-frequency 1Hz rTMS applied to the 
right cerebellar hemisphere decreased ICF at 10 ms ISI for up to 20 minutes to the 
contralateral motor cortex (Fierro et al., 2007). In contrast, Oliveri and colleagues 
(2005) found that cerebellar 1Hz rTMS increased ICF at 15ms for up to 30 minutes. 
There was no change in the CSP following cerebellar rTMS (Oliveri et al., 2005). 
The application of TBS to the cerebellum to modulate intracortical circuits of the 
motor cortex in healthy subjects was investigated by Koch and colleagues (2008).  
They applied cTBS and iTBS to the cerebellum and examined the SICI, LICI and the 
MEP amplitudes before and after TBS. Following cTBS there was a decrease in the 
MEP amplitude using stimulus intensities of 80% and 90% of AMT, with an 
additional reduction of SICI (3ms) and an increase in LICI.  iTBS at 80% produced an 
increase in MEP amplitude and a decrease in ICF and LICI (100ms). The modulation 
of LICI and SICI could reflect modulation of the GABA circuits. Even though the 
results were variable, they demonstrate that TBS applied to the cerebellum can 
modulate the cerebello-thalamo-cortical pathways and have a facilitatory or inhibitory 
effect on the motor cortex (Koch et al., 2008). 
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Subsequently Popa and colleagues (2010) studied the effects of 1Hz rTMS, cTBS and 
iTBS on CBI. cTBS and 1Hz rTMS over the right cerebellum exerted a significant 
suppression of CBI to the contralateral motor cortex for up to 30 minutes. This effect 
was not observed following iTBS. The study suggests that the intracortical inhibition 
observed over the contralateral motor cortex is due to transynaptic activation of the 
Purkinje cells and the parallel fibers in the cerebellar cortex. The activation of the 
Purkinje cells results in inhibition of the dentate nucleus, and the dentate-thalamo-
cortical connections, which facilitate cortical activity under normal conditions (Popa, 
Russo, & Meunier, 2010). 
 
 A number of studies have explored the behavioral effects of rTMS on the cerebellum 
(Colnaghi et al., 2011; Fierro et al., 2007; Gerschlager, Christensen, & Bestmann; 
Rothwell, 2002).  Cerebellar TMS has been demonstrated to have an effect on the 
perception of time, memory and the motor system. rTMS has been used in studies to 
investigate the performance of finger tapping, which was combined with auditory and 
visual cues following cerebellar stimulation. The results suggest that rTMS interfered 
with the intracortical neural networks, by increasing the variability in the finger 
tapping and changed excitability in a localised region of the cerebellum. This further 
identified the important behavioral relationship that the cerebellum has with neural 
processing (Del Olmo, Cheeran, Koch, & Rothwell, 2007). TMS has been applied to 
examine time perception, which is important in motor and cognitive functions. The 
cerebellum has an important role in timing and 1Hz rTMS impaired the subjects’ 
perception of time when it was applied over the left cerebellum. The Purkinje cells 
have a crucial role in LTD and it has been suggested these cells are also important in 
learning dependent timing. The authors proposed that 1Hz rTMS to the cerebellum 
interfered with the physiological activity of these Purkinje cells to induce inhibition, 
similar to LTD (Koch et al., 2007).  
 
The cerebellum’s involvement in non-motor systems has been regularly explored 
throughout the literature. The ability for the cerebellum to be modulated by TMS and 
the impact that this has on other non-motor areas is integral to the treatment potential 




The role of the cerebellum as a target to abort seizures has been explored in animal 
studies. Cooke and Sinder (1955) demonstrated that surface electrical stimulation over 
the cerebellum in a cat model could abort seizures (Cooke & Sinder, 1955). This was 
also observed in a cat seizure model in a study conducted by Hutton and co workers 
(1972). The cerebellar vermis and dentate nucleus was stimulated, resulting in seizure 
inhibition (Hutton, Frost, & Foster, 1972). 
 
One of the first studies to apply electrical cerebellum stimulation in patients with 
refractive epilepsy was Cooper and colleagues (1976). Initially the cerebellar cortex 
was stimulated using implanted electrodes with high frequency electrical stimulation, 
which produced seizure reduction in patients with drug resistant epilepsy. The 
inhibitory effects that were demonstrated during these studies have been attributed to 
the effect of the Purkinje cells on the deep cerebellar nuclei, and the cerebello-
thalamo-cortical pathway (Cooper, Amin, Riklan, Waltz, & Poon, 1976). 
 
The above literature suggests that electrical stimulation of the cerebellum aborts 
seizures, although the exact mechanism behind this process still remains unclear. 
While direct electrical stimulation of the cerebellum is a promising treatment, it is 
limited and requires surgery. On the other hand, the application of a non-invasive, 
relatively pain free treatment such as TMS could be advantageous in treating epilepsy 
(Fountas, Kapsalaki, & Hadjigeorgiou, 2010). 
 
Cerebellar stimulation was explored in the treatment of refractive patients with multi-
focal epilepsy (Brighina, Daniele, Piazza, Giglia, & Fierro, 2006). The study used 
high frequency cerebellar rTMS that was applied contralateral to the epileptic focus, 
and each patient underwent 20 sessions in which 5Hz rTMS was applied in two trains 
of 50 stimuli that were separated by a 50s interval. The study concluded that whether 
the patients had a single or multiple epileptic foci, rTMS over the cerebellum 
significantly reduced the patient’s seizure frequency. The study’s findings were 
limited due to small sample size and some participants displayed little reduction in 
seizures during the post-TMS phase. Although this study suggested a beneficial effect 




Cerebellar stimulation has also been investigated in other conditions. Recently, Brusa 
and co workers (2012) investigated cTBS of the cerebellum and its ability to reduce 
levodopa induced dyskinesia (LID) in patients with Parkinson disease. The study 
confirmed that there was a reduction of LID following weak bilateral cerebellum 
cTBS. The study further addressed whether the cTBS effect was due to changes in 
other interconnected brain areas or whether it was due to a direct modulation of the 
cerebellum (Brusa et al., 2012). 
 
1.7. Aims and objectives 
 
The aim of the present study was to investigate the effects of 30Hz cerebellar TBS on 
the contralateral motor cortex, using single pulse TMS and the combination of TMS 
and EEG to assess cortical excitability in healthy volunteers. Although previous 
studies have investigated MEP and paired pulse measures of cortical excitability 
following cerebellar rTMS and TBS, this has not been investigated using TMS-EEG.  
Our hypotheses were: 
 
a) That 30Hz TBS applied to the cerebellum would have similar effects on 
MEP amplitude to 50Hz TBS. ie. iTBS will increase MEP amplitude, and 
cTBS will reduce MEP amplitudes obtained from the contralateral motor 
cortex.  
 
b) That changes in the N100 waveform of the TEP would reflect changes in 
intracortical inhibition. Ie. iTBS would decrease and cTBS would increase 















Sixteen healthy volunteers, nine male and seven female, aged 18-30 years, were 
recruited within the University of Otago by advertisement. Thirteen participants were 
right handed and three left-handed. The exclusion criteria were a medical history of 
neurological disorders, including epilepsy, and contraindications to transcranial 
magnetic stimulation: cardiac pacemakers, electronic implants, and metal aneurysm 
clips. The study received prior approval from the Central Regional Ethics Committee 
New Zealand and written informed consent was obtained from each participant. 
 
 2.2 Electromyography (EMG) 
Surface EMG was recorded from the first dorsal interosseous (FDI) muscle of the 
right hand using 1cm diameter AgCl disc electrodes with the active electrode placed 
over the muscle belly, a reference electrode over the metacarpophalangeal joint of the 
forefinger and a ground electrode on the dorsum of the hand. The electrodes were 
connected to an electromyography system (Medelec Synergy). Motor evoked 
potentials (MEP) were recorded using a time base of 250 ms, a sensitivity of 5 mV 
per division, high pass filter of 3 Hz and low pass filter of 10 kHz.  
 
2.3 Transcranial Magnetic Stimulation (TMS)  
A Magstim Rapid2 magnetic stimulator and air-cooled 70mm figure of eight coil was 
used for TMS. A Magstim placebo coil, which mimics the typical “click” of the 
genuine coil, but without the magnetic stimulation, was used as a control condition. 
The coil was positioned over the left motor cortex with the handle projecting 
posteriorly, at a 30-40 degree angle to the midsaggital line. The resting motor 
threshold (RMT) was defined as the lowest stimulus intensity required to produce a 
MEP of at least 50 microvolts (µV) in greater than 50% of trials, with the FDI fully 
relaxed. The active motor threshold (AMT) was defined as the lowest intensity 
required to produce MEP of at least 200 µV in greater than 50% of trials, while the 
participant exerted a 2 kg force on a pinch grip dynamometer (B&L pinch gauge). 
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Active and resting MEPs were ecorded using a stimulation intensity of 110% of 
RMT. MEP amplitudes were measured peak to peak, MEP latency was measured 
from the beginning of the stimulus to the start of the MEP and the cortical silent 
period was measured as the time from stimulus to the resumption of EMG activity. 
 
2.4 Theta burst stimulation (TBS) 
30Hz TBS was applied to the right cerebellum at an intensity of 80% for the first 
eight subjects and then at 90% for the last eight subjects. The point of stimulation was 
3 cm lateral to the midline and 1 cm below the inion.  The TMS coil was positioned 
vertically with the handle placed upwards. This position has been previously shown to 
optimize inhibition of the contralateral motor cortex (Ugawa et al., 1995; Werhahn et 
al., 1996). cTBS consisted of 30Hz stimulation, in 3-pulse bursts repeated every 
200ms (5 bursts per second) to a total of 600 pulses. (Wu et al 2012)  For iTBS two-
second trains of TBS were repeated every 10 seconds for a total of 600 pulses.  Sham 
TBS was applied using either the cTBS or iTBS pattern, but using the placebo coil.  
The iTBS and cTBS stimulation patterns were alternated between participants for the 
sham sessions.  
 
2.5 Electroencephalography (EEG)  
EEG was recorded using an EasyCap 32 channel electrode cap (Easycap GmbH, 
Herrsching, Germany) connected to a Synamps RT EEG system (Compumedics 
Neuroscan, Texas, USA).  The electrodes were positioned on each individual’s head 
according to the 10-20 electrode placement system. An additional electrode was 
placed below the eye, to identify blink artifact.  Electrodes were referenced to an 
electrode placed on the vertex, posterior to the Cz electrode. Each electrode 
placement was preceded by cleaning the scalp with alcohol and NuPrep (skin prep 
gel). The impedances of the overall EEG cap was then checked to ensure that they 
were they were less than 5Ω.  Neuroscan Acquire software was used to record the 
EEG in DC mode at a sampling rate of 20 kHz, with a high pass filter of 500 Hz.  
Timing of the magnetic pulses was relayed to the EEG system via a trigger signal 
from a Digitimer Neurolog System, which also triggered the Magstim Rapid2 
stimulator.  The Neurolog System was, in turn, controlled by an E-Prime program, 
which produced a signal at pseudorandomised intervals ranging between 3 and 5 
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seconds. The EEG recordings were down-sampled to 1 kHz offline, using Neuroscan 
Edit software. They were then exported to EEGLAB (Delorme and Mackeig, 2004), a 
Matlab-based program (Mathworks®). Portions of the EEG containing excessive 
artifact were removed and pre- and post-TBS recordings were combined into one file 
for each session. Independent component analysis (ICA) was carried out using the 
EEGLAB ‘runica’ command. The EEG was then epoched from 200 ms prior to the 
TMS stimulus to 500 ms post-stimulus.  The epochs were baseline corrected using the 
-200 to -50 ms pre-stimulus interval as the baseline. Components containing blink or 
TMS artifact (approximately 25% of components) were removed. The residual EEG 
was then processed using principal component analysis and further artifact-containing 
components were removed. The channel event related potentials were then extracted 
and averaged.  A low pass filter of 30Hz (24 dB/Oct) was used for display purposes. 
The TMS-evoked potentials obtained before and after each TBS or sham treatment 
were averaged across subjects and inspected for differences. The N100 amplitude was 
calculated as the mean amplitude of the waveform between 90 and 110 ms after the 
magnetic stimulus.  The N100 at C3 was used for statistical analysis as this was the 
electrode closest to the stimulating coil. 
 
2.6 Experimental Design  
The study involved two experiments.  In experiment 1, the first eight participants 
received TBS at a stimulus intensity of 80% of AMT; in experiment 2, the second 
eight participants received TBS at 90% of AMT. Each participant underwent three 
sessions that were carried out at least one week apart. In each session one of the three 
TBS protocols was applied to the right cerebellar hemisphere: 30Hz iTBS, 30Hz 
cTBS or sham TBS. The order of the sessions was counterbalanced between 
participants. The participants were blinded to each session. Follow up questions were 
asked to ensure they were not aware of the treatment administered.  
 
In each session, the electrode cap was applied and electrode impedances were 
checked. Electrodes were also applied to the right FDI, and the active and resting 




active MEP were obtained from the left motor cortex. The stimulation intensity that 
was applied over the cerebellum was calculated based on the subjects average resting 
MEP obtained from the left motor cortex. This was measured for every subject as the 
threshold can vary depending on the age and gender of each the subject,	  and factors 
like skull thickness. This is a commonly used method for determining stimulus 
intensities to be used for treatment. In some studies a correction has been used to 
compensate for the different depth of the cerebellum, but we did not have 
neuroimaging on the participants, so did not do this.	  The	  relatively	  small	  number	  of	  
MEP	  was	   used	   because	   the	   experimental	   procedures	   were	   already	   quite	   long,	  
EEG recording then commenced and each participant received 28-32 single pulses of 
TMS to the left motor cortex at a stimulus intensity of 90% RMT, at intervals of 3-5 
seconds. 28-32 single pulses were used based on previous literature and our own 
previous experience.  
 
One of the three TBS protocols was then applied to the right cerebellar hemisphere.  
After delay of two minutes a further 28-32 pulses of TMS were applied to the FDI 
‘hotspot’ of the left motor cortex, while EEG was recorded. Finally, motor thresholds 
and MEP were again recorded 5-10 minutes after the end of TBS. Three participants 
in experiment 1 and six participants in experiment 2 underwent additional MEP 
recording at 20 and 30-minute after the end of the TBS treatment. This was performed 
in some of the later participants, when the procedures had become more efficient and 
less time had been required to set up the electrodes.  Earlier in the study, the length of 
time taken was such that the experiment would have taken too long and exceeded 






Figure 2.1. Schematic presentation of the experimental protocol. Experiments 1 and 
2 differed in the stimulus intensity used for TBS treatment. 
 
Figure 2.2. Setup for recording Motor Evoked Potentials and TMS Evoked 
Potentials. The figure of eight coil was placed on the participant’s head over the left 
the motor cortex as described in the text. The 10-20 electrode cap was used to record 







































































2.7 Data Analysis  
 
The MEP data from experiments 1 and 2 were analysed separately. The mean 
thresholds, amplitudes, latencies and cortical silent period, and N100 amplitudes 
before and after TBS were determined for each session. MEP amplitudes were 
measured peak to peak, MEP latency was measured from the beginning of the 
stimulus to the start of the MEP and the cortical silent period was measured as the 
time from stimulus to the resumption of EMG activity. 
   Analysis was carried out in SPSS statistics software, using a mixed model analysis 
of variance (ANOVA).  Two methods were used: (a) In an initial repeated measures 
analysis, treatment type (iTBS, cTBS and sham TBS) and Time (Pre- or Post-
treatment) were used as fixed effects factors, with subject as a random factor. (b) In 
the second analysis the dependent variable was the log of the post-treatment value for 
each parameter and Treatment Type and SI were fixed factors, with Subject and the 
log of the pre-treatment value as random factor and covariate respectively.  In the case 
of the N100 amplitude, Electrode was used as an additional factor. Data was 
considered significant at p<0.05, two tailed.  
 




3.1 Motor Evoked Potentials 
Appendix 1 shows the mean parameter values before and after TBS treatment for 
experiments 1 and 2. 
 
Experiment 1: TBS at 80% AMT 
There were a total of eight subjects in this experiment; four males and four females, 
with a mean age of 22 years (range 20-26years). Six of the subjects were right handed 
and two were left-handed. The procedure was well tolerated by all the subjects and all 
subjects completed all three sessions.  
 
In the repeated measures mixed model analysis, there was an overall effect of Time:  
CSP was significantly larger after treatment, 188 (ms) compared to 178 (ms) pre-
treatment F(1,7) = 25.15, p = 0.001. There were no other significant effects on MEP 
parameters.  
 
With Regard to TEP, the appearance of the waveforms suggested an increase in the 
N100 amplitude at C3 following iTBS (Figure 3.3 and 3.4), while sham stimulation 
did not appear to produce any change in the waveform (Figure 3.6). For stimulation at 
80% of RMT, mixed ANOVA with factors Treatment x Electrode, with pre-treatment 
N100 amplitude as a covariate revealed a significant effect on treatment on N100 
amplitude, F (2,348)= 197.80, p < 0.001. Post-hoc analysis showed that values were 
significantly greater after iTBS than after Sham or cTBS p < 0.05 (Figure 3.7)  
 
 Experiment 2: TBS at 90% of AMT 
This experiment included eight subjects: four males and four females, with a mean 
age of 22 years. One of the subjects was left-handed and all others were right handed. 
During this experiment, one participant withdrew from the iTBS session because of 
discomfort related to stimulation of cervical muscles. Two of the participants 




 stimulation, but completed all three sessions. An additional subject experienced neck 
spasm the night after the treatment, and one other subject experienced dizziness the 
day after their first session. It was uncertain whether this was due to the study 
procedures.  
 
Otherwise, the procedures were well tolerated. 
 
Using repeated measures ANOVA there was an effect of Time on resting MEP 
amplitude which was greater after treatment than before treatment, (1.543±248 vs. 
1.161±118 mV), F(1,60) = 5.53, p = 0.022. Using the pre-treatment value as 
covariates, there was no significant effect of treatment type on active latency F(2, 14) 
= 3.46, p=0.06 or the active amplitude F(2,9) = 3.98, p=0.06. There was an effect of 
treatment type on resting amplitude, F(2,14) = 4.28, p=0.03. Resting amplitude was 
lower after cTBS than after sham TBS (Figure 3.1). There was also a significant 
effect of treatment type on CSP F(2,13) = 4.87, p=0.026. CSP was increased 






Figure 3.1. Effects of 90% cerebellar TBS on Resting MEP amplitude. Following 





































Figure. 3.2. Effects of 90% cerebellar TBS on CSP. Following iTBS there was an 
increase in the CSP compared to sham TBS. *p=0.026. 
 
Mixed ANOVA with factors Treatment x Electrode, with pre-treatment N100 
amplitude as a covariate revealed a significant effect of Treatment on N100 
amplitude, F(2,455) = 6.17, p = 0.002.  Post-hoc analysis showed that values were 
significantly greater after iTBS than after Sham or cTBS, p < 0.05 (Figure 3.7 and 
3.8). There was no effect of Electrode, and the effects appeared to be widespread, 

























Figure 3.3.  Effect of 80% cerebellar iTBS on the TMS evoked potential. The N100 
potential was more prominent after treatment (red) than before (blue). The arrow 
indicates the position of N100 potential.  
 
 
Figure 3.4.  Effect of 90% cerebellar iTBS on the TMS evoked potential. The N100 









Figure 3.5.  Effect of 80% cerebellar cTBS on the TMS evoked potential. The N100 




Figure 3.6. Effect of sham cerebellar TBS on the TMS evoked potential. The N100 









Figure 3.7. Effects of cTBS, iTBS and Sham on the N100 amplitude when applied 
over the lateral cerebellum at 80% RMT. Mean post-iTBS amplitude was 






































Figure 3.8. Effects of cTBS, iTBS and Sham on the N100 amplitude when 
applied over the lateral cerebellum at 90% RMT. Mean post-iTBS amplitude was 




















Figure 3.9.  Effect of iTBS at 90% AMT on TMS-evoked potentials.  EEG montage 
showing TMS-evoked potentials at all electrode sites. Pre-iTBS TMS evoked 
potential (blue) and post-TMS evoked potentials (red) are demonstrated. The N100 










3.2   30 minute MEP results  
30 minutes post stimulation there was no significant effect of treatment type on the 
CSP. There was a significant effect on active and resting MEP amplitudes following 
90% iTBS. Active MEP amplitude remained elevated when compared to sham, 
F(2,11) = 11.06, p=0.05 (Figure 3.11). Resting amplitude at 30 minutes post iTBS 
possibly remained elevated, although this fell just short of significance, F(2,11) = 
11.52, p = 0.05 (Figure 3.12). Thus, the effects on active and resting MEP amplitudes 
appeared to persist up to 30 minutes following TBS treatment, although the effect on 











Figure 3.10 Effects of treatment on Active amplitude 30 minutes post stimulation. 










































Figure 3.11 Effects of treatment on Resting amplitude 30 minutes post stimulation. 




































In this study, we applied two different TBS protocols to the lateral cerebellum and 
demonstrated their effects on excitability in the contralateral human motor cortex, as 
compared with placebo. One protocol, iTBS, has previously been shown to produce 
corticospinal facilitation when applied directly to the motor cortex (Huang et al., 
2005). The other, cTBS, has been shown to produce inhibition (Huang et al., 2005). In 
experiment 1, following iTBS and cTBS at 80% AMT there were no significant 
effects on MEP amplitude and CSP. In experiment 2, following cTBS at 90% AMT 
there was reduction in excitability in the contralateral motor cortex, compared to 
placebo, as demonstrated by reduced resting MEP amplitude. Following 90% iTBS 
there was increase in the CSP. Following both 80% and 90% iTBS there was an 
increase in the N100 potential. These results provide further evidence that cerebellar 
TBS can modulate excitability of the contralateral motor cortex, an effect mediated 
most likely via the cerebello-thalamo-cortical pathway.  
 
4.1.    Effect of cerebellar TBS on MEP 
 
The MEP findings can be compared to those described by Koch et al. (2008) who 
demonstrated a reduction in resting MEP amplitude following 50Hz cTBS over the 
left lateral cerebellum using the same landmarks (1 cm below the inion and 3 cm 
lateral to midline) at 80 or 90% AMT and an increase in resting MEP amplitude 
following 50Hz iTBS at 80% AMT (iTBS at 90% AMT was not investigated). In 
contrast to our study, they also studied paired pulse measures of cortical excitability, 
and found a decrease in SICI at 3ms following cerebellar cTBS at 80 or 90% AMT 
and an increase in LICI at 100ms following cerebellar cTBS at 80% AMT.   
 
Following 80% iTBS stimulation Koch et al. (2008) found a decrease in ICF and LICI 
at 100ms. It is likely that LICI and the CSP relate to the same inhibitory mechanisms 
and the decrease in LICI following iTBS in the Koch et al. (2008) study is therefore 
in contrast to our finding of prolonged CSP after iTBS at 90% AMT. Koch et al. 




A possible explanation for the variation in these results obtained from each study 
could be due to the type of Magstim stimulator that was used. Koch et al. 2008 used a 
mono-phasic stimulator where the current study used a bi-phasic stimulator to record 
MEP it is possible that different neural circuits were activated by the magnetic fields. 
This contrast in findings warrants further research into the depth at which the 
stimulation occurs.  
 
What is consistent between the two studies is that cerebellar cTBS decreased MEP 
amplitude. Measurements reflecting intracortical inhibition were less consistent, as 
our study suggested that iTBS caused increased inhibition (increased CSP and N100) 
while Koch et al. (2008) demonstrate decreased inhibition (LICI). It is likely that TBS 
modulates the intracortical circuits via the cerebello-thalamo-cortical pathway; this is 
because it is the main efferent pathway from the cerebellum to the cortex (Koch et al., 
2008). A significant difference between our study and that of Koch et al. (2008) was 
that we used 30Hz rather than 50Hz TBS. Two studies have shown that 30Hz TBS 
produces similar neurophysiological effects to 50Hz when applied to the primary 
motor cortex (Wu et al., 2012; Gilbert, Shahana, Huddleston, & Wu, 2012). In a prior 
study, we demonstrated N100 effects using iTBS applied to the motor cortex 
(unpublished). However 30Hz TBS has not previously been reported in studies of 
non-invasive cerebellar stimulation. 30Hz stimulation has the advantage that it can be 
applied at adequate stimulus intensity using the Magstim Rapid2 stimulator, whereas 
50 Hz requires the Magstim Super Rapid2 stimulator. 
 
MEP amplitude is dependent on changes in the spinal motor neurons as well as the 
cortico-spinal neurons within the motor cortex; these changes can occur at a spinal 
and cortical level or a combination of the two. The effects of TBS are likely to occur 
at cortical level (Wassermann, 1998), however, and the amplitude of the MEP reflects 
the excitability of the motor cortex, which is determined by the balance between 
inhibition and facilitation  (Day et al., 1989; Di Lazzaro, 2004). Without paired pulse 
TMS studies, it is difficult to determine whether an increase in the MEP amplitude is 
due to a decrease in inhibition or an increase in excitation or both, and conversely, a 
reduction in MEP amplitude could be due to a reduction in excitation or increased 




Variable findings are not unusual in TMS experiments. Like cTBS, 1Hz rTMS is 
reported to produce inhibitory effects when applied directly to the motor cortex.  
Previous 1Hz rTMS cerebellar studies have demonstrated variable results (Fierro et 
al., 2007; Gerschlager, Christensen, & Bestmann; Rothwell, 2002; Oliveri, Koch, 
Torriero, & Caltagirone, 2005).  
 
Gerschlager et al. (2002) studied the effects of 600 stimuli at 1 Hz over the right 
cerebellum and showed a decrease in corticospinal excitability (decreased MEP 
amplitude) in the right arm. Fierro et al. (2007) studied SICI and ICF following 1 Hz 
rTMS to the right cerebellar hemisphere (900 pulses) and demonstrated a decrease in 
ICF in the left motor cortex. In contrast, Oliveri et al. (2005) carried out a similar 
experiment using 1Hz at a stimulus intensity of 90% of RMT and showed that ICF 
and MEP were increased in the contralateral motor cortex. CSP was unchanged. 
Studies of cerebellar TBS (ours and Koch et al.) appear to demonstrate that cTBS 
reduces MEP amplitude obtained from the contralateral motor cortex. The variability 
in these effects could be based again on the level of stimulation that occurs. The 
thickness of the participant’s skull across all these experiments could vary 
significantly, additionally affecting the site of stimulation.  
 
One further study provides evidence that cerebellar cTBS (600 stimuli) has the ability 
to effectively inhibit the cerebellar projections to the motor cortex. The study of Popa 
et al. (2010) showed that 1Hz rTMS (900 stimuli) and cTBS abolished the CBI, 
presumably because MEP amplitude cannot be reduced any further as it is already 
maximally inhibited. The study used similar stimulation location to our study, but the 
optimal position for stimulation was not based around manual measurements but was 
defined based on the help of magnetic resonance imaging (MRI) neuronavigation. 
Popa et al., (2010) studied the effects of 1Hz on the CBI paradigm, so they did not 





The relationship between CBI and LICI has been described by Daskalakis and 
colleagues (2004). CBI and LICI were both decreased as a result of increasing the TS, 
although the mechanism of action appears to be different as the time course of CBI 
(10ms) and LICI (100ms) are different. Interestingly CBI was reduced in the presence 
of LICI, which demonstrates that these measures may be activating subcortical sites. 
The study suggests that based on these results it is possible that at the level of the 
motor thalamus the inhibitory cerebellothalamic pathway is disrupted. Overall the 
study concludes that there is potential for excitatory and inhibitory changes in the 
motor cortex following cerebellar stimulation  (Daskalakis et al., 2004). 
 
The findings from the studies of cerebellar rTMS and TBS appear to be counter-
intuitive.  CBI as demonstrated originally by Ugawa et al. (1995) is thought to be due 
to excitation of the Purkinje cells, which results in inhibition of the dentate nucleus 
and the dentato-thalamo-cortical pathway. Why then should cTBS, which causes 
inhibition when applied to the cortex, cause excitation of the Purkinje cells rather than 
inhibition?  
 
The distribution of cells in the cerebellar cortex is complex; the cellular structures 
stimulated could influence the effect on the cerebral cortex. We postulate that cTBS, 
which uses lower stimulation intensity than single pulse CBI experiments, may 
stimulate interneurons, such as the stellate and basket cells rather the Purkinje cells 
directly, and these may exert an inhibitory effect on the (deeper) Purkinje cells. This 
would explain why the present study as well as the study of Koch et al. (2008) 
demonstrated decreased MEP following cTBS. 
 
Another issue not discussed so far is that there was evidence of an effect of time (pre-
or post-stimulation) on CSP in experiment 1 and on resting MEP amplitude in 
experiment 2. It is possible that the methods we used to assess cortical excitability –
MEP and TEP - themselves alter cortical excitability. A significant number of stimuli 
were applied in recording these measures, and although the stimulation frequency was 
generally low (3-7 seconds between stimuli) it is possible that these stimuli may have 
altered these parameters. One advantage of our study design is that we included a 
sham treatment, so that our findings were based on a comparison between active and  
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 sham treatments the differences between real TBS and sham therefore due to TBS 
and not due to the procedures used to measure the effects of TBS.  
 
Another concern in studies of cerebellar TMS is that the findings could have resulted 
from stimulation of the cervical nerve roots. This is an important issue to highlight as 
the nerves that innervate the spine, are close to the site of stimulation, as evidenced by 
occasional occurrence of neck twitching during stimulation. Previous studies have 
identified that single pulse stimulation over the cerebellum has both central and 
peripheral actions (Gerschlager et al., 2002). Studies using rTMS and TBS protocols 
have explored the same type of stimulation applied over the cervical roots. The 
findings suggested that it was unlikely that results were affected by stimulation of the 
brachial plexus (Popa et al., 2010). Thus it is doubtful that our findings were due to 
stimulation of the cervical nerves. However, a drawback of our study is that we did 
not formally explore this. 
 
In addition to studying the immediate effects that cTBS and iTBS had on the 
cerebellum and the contralateral motor cortex, we explored the duration of the effect 
on the MEP, in a subset of participants. The findings showed that 30 minutes post- 
stimulation there was an apparent increase in the active amplitude after iTBS and a 
decrease in the resting amplitude following cTBS. Even though TBS appeared to be 
persistent or have delayed effects, it is difficult to draw further conclusions because 
the number of participants who had delayed testing is too small. We did not repeat the 
TEP, so the duration of those effects was not investigated. The duration of effect 
following TBS is important. Previous rTMS studies have confirmed that when applied 
over the motor cortex the MEP can be affected for several minutes after the end of the 
stimulation (Chen et al., 1997; Stefan, Kunesch, Cohen, Benecke, & Classen, 2000; 
Tsuji & Rothwell, 2002). Much longer lasting effects would be necessary for 
cerebellar TBS to be useful in treatment. Studies using rTMS in disease have 
demonstrated prolonged benefits in some conditions, usually by giving repeated 






4.2   Effects of TBS on TEP 
 
MEP have provided useful measures of cortical excitability, although limited to the 
motor cortex. The combination of TMS and EEG provides an alternative method of 
assessing the effects of TMS in health and disease. Previous studies have shown that 
the N100, which is the negative waveform that occurs about 100 ms after the 
stimulus, is a measure of intracortical inhibition (Helfrich et al., 2012). There is recent 
additional evidence to confirm that the N100 is a reliable marker of cortical inhibition. 
Casula et al. (2014) demonstrated that following 1Hz rTMS to the primary cortex 
there was an increase in the P60 and N100 components and a decrease in the 
amplitude of the MEP (Casula et al., 2014). These findings are in contrast with our 
findings that following cerebellar iTBS there was an increase in the N100 amplitude 
in CSP both inhibitory markers. These findings were unexpected however, 
considering previous evidence that iTBS to the cerebellum results in increased MEP 
amplitude (Koch et al., 2008).  
 
The explanation may be that iTBS activates both facilitatory and inhibitory networks, 
and the amplitude of the MEP depends on which process is dominant. There is 
evidence to suggest a correlation between the MEP amplitude and the CSP (Wehahn, 
2007), although studies have been unable to reproduce similar correlation between the 
MEP amplitude and the N100 (Bender et al., 2005). The CSP and the N100 have both 
been described as a measure of inhibition and we found that iTBS increased both CSP 
and N100 amplitude (Rogasch, Daskalakis, & Fitzgerald, 2013; Nikulin, Kicic, 
Kahkonen, & Ilmoniemi, 2003). 
 
We did not repeat the TEP after a delay, so the duration of the TEP effects was not 
investigated. 
 
4.3   Mechanism of TBS effects on the Cerebellum 
 
A number of animal and human studies have explored the cerebello-thalamo-cortical 
pathway and showed that the projections can terminate on either excitatory or 
inhibitory neurons. The axons of the Purkinje cells are the main inhibitory projection  
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 to the dentate nucleus (which is the main output for the cerebellum), and projections 
from the dentate nucleus terminate in the thalamus, where a number of excitatory and 
inhibitory pathways project to the motor cortex. Depending on the location of 
stimulation and the layer of the cerebellar cortex activated the cortical effect could 
vary. However, single pulses to the cerebellum have generally been shown to reduce 
MEP elicited from the opposite motor cortex milliseconds later (Ugawa et al., 1995). 
 
Previous studies that have used the paired pulse paradigm and rTMS suggest that 
stimulation of the cerebellum results in activation of this direct Purkinje output 
pathway causing either a reduced or increased amount of tonic facilitation of the 
contralateral motor cortex. We postulated that cTBS would have an inhibitory effect 
on the cerebellum (analogous to its inhibitory effect when applied to the motor cortex) 
and this would then result in excitation of the contralateral motor cortex, by 
disinhibiting the tonic facilitation maintained by the dentate nucleus. This would be 
consistent with the findings of Oliveri et al. (2005), using 1 Hz rTMS. However this 
was not demonstrated in the TBS study of Koch et al. (2008) or by the present study, 
where cTBS appeared to have an overall inhibitory effect on contralateral motor 
cortex excitability. 
 
On the other hand, the stimulation intensities used in 1Hz TMS are higher than those 
used in TBS and it is possible that the results of stimulation are affected by 
stimulation intensity; higher intensities are likely to stimulate deeper levels of the 
cerebellar cortex.  This may explain the contrary findings of Gerschlager et al. (2002) 
and Oliver et al. (2005). 
 
In the study of Koch et al. (2008), iTBS had the opposite effect to cTBS, resulting in 
increased MEP amplitude obtained from the contralateral motor cortex. We did not 
demonstrate a significant effect of iTBS on MEP amplitude, but iTBS produced 
increased intracortical inhibition as shown by increased CSP and N100.  The effect on 
excitability of the contralateral motor cortex is presumably mediated through the 







Figure 4.1. Cerebello-thalamo-cortical connections. The blue circles superimposed 
on a sagittal diagram of the brain each represent a population of neurons that mediates 
an inhibitory or excitatory process.  The red lines represent inhibitory pathways 
whereas the blue lines represent facilitatory pathways. The thick lines represent the 
proposed cerebello-thalamic-cortical pathway as well as the inhibitory effect of the 
granule and basket cells on the Purkinje cells resulting in inhibition of the 
contralateral motor cortex.  Thus excitation of granule and basket cells by iTBS would 
increase facilitation of the motor cortex, while cTBS would have the opposite effect 
GC = granule cells, PC = Purkinje cell, BC = basket cells, VL/Thalamus = Ventro- 
lateral thalamus, DCN = deep cerebellar nuclei, PN = Pontine nucleus, IO = Inferior 






The cerebellum is a very complex structure and structurally quite different from the 
motor cortex, so the effects of rTMS or TBS on the motor cortex are not necessarily 
the same in the cerebellar cortex. In the motor cortex iTBS appears to have a 
facilitatory effect and cTBS an inhibitory effect on pyramidal cells. In the context of 
the cerebellum the Purkinje cells are the main output to the dentate nucleus, and it is 
possible that cells other than the Purkinje cells could have been modified by TMS, 
with secondary effects on the Purkinje cells. For example, iTBS excitation of the 
granule cells or basket cells (directly or via the mossy fibers that come from the 
pontine nucleus via the pontocerebellar pathway) could cause inhibition of the 
Purkinje cells on which they synapse. This would in turn result in reduced (inhibitory) 
Purkinje output to the DCN causing more tonic facilitation of the contralateral motor 
cortex via the dentato-thalamo-cortical pathway (Figure 4.1.) It is also possible based 
on TMS protocols that at the level of the motor cortex, iTBS could be essentially an 
inhibitory pattern that acts on these inhibitory neurons directly.   
 
Conversely, cTBS could be acting by inhibiting the cerebellar interneurons that 
synapse on the Purkinje cells, thus disinhibiting the Purkinje cells and decreasing the 
facilitatory effects of the dentate nucleus on the opposite motor cortex. This 
explanation, that it is the granule and basket cells that are primarily stimulated, seems 
credible, as they are more superficial than the Purkinje cells (see Figure 4.2). The 
cerebellum is not as close to the stimulating coil during TMS as the motor cortex and 
the stimulation intensity may very critical to the outcome measured. With higher 
stimulation intensity it is possible that direct stimulation of Purkinje cell could occur. 







Figure 4.2. A basic illustration of the cortical layers of the cerebellum. The diagram 
shows the basic interaction of the cells within the cerebellum. Note that the stellate 
and basket cells have inhibitory synapse on the Purkinje cells. The plus and minus 
symbols represents the excitation (+) and inhibition (-) between each of the cells 
types. PC = Purkinje cell, SC = Stellate cell, GC = Granule cell, DCN = dentate 
cerebellar nucleus, MF = Mossy fibers, PF = Parallel fibers, BC = Basket cells, CF = 
Climbing fibers (Diagram by Harrington., 2014).  
 
 
4.4.     TBS as Treatment for Epilepsy and other Neurological Conditions 
 
The current experimental findings and previous literature provides evidence that TBS 
has potential to be applied as a therapy for a number of neurological conditions. The 
ability to stimulate the cerebellum provides an alternative site for non-invasive brain 
stimulation as a means for altering cortical excitability in the motor cortex and other 
areas of the cortex. This may be useful in a number of conditions such as epilepsy and 




The MT have variously been shown to be increased or decreased in patients with 
generalized epilepsy when compared to controls, whereas in patients with focal 
epilepsy there was an increase (Brigo et al., 2012; Reutens & Berkovic, 1992; 
Tataroglu et al., 2004; Werhahn, 2000). Likewise while, the CSP has been 
demonstrated to be increased in patients with generalised and focal epilepsy, there 
was one study that demonstrated an increase, suggesting a reduced amount of 
inhibitory networks (Tataroglu et al., 2004; Akgun et al., 2009). Paired pulse studies 
have demonstrated evidence that ICI and LICI are decreased in both types of epilepsy. 
Thus the literature concerning cortical excitability in epilepsy is rather inconclusive 
and it is unclear whether the problem is due to reduced inhibition or increased 
facilitation. This raises the question: should the primary target for treatment be 
intracortical inhibition as shown by the CSP and N100 or the MEP amplitude? From 
the current experimental findings cerebellar iTBS appears to increase the CSP and the 
amplitude of the N100 potential, suggesting increased intracortical inhibition. 
Nevertheless it appeared to increase MEP amplitude in the study of Koch et al. 
(2008). In contrast cTBS effectively reduced the MEP amplitude in both our study 
and Koch et al. 2008.  
 
Therefore, based on the current evidence, cerebellar cTBS might be the best TBS 
paradigm to trial in epileptic patients based on its overall ability to reduce excitability 
in the motor cortex, as reflected in the MEP amplitude. On the other hand iTBS 
appears to increase intracortical inhibition as reflected in the N100 amplitude. These 
results obtained are thus contradictory which makes it difficult to proceed with a 










5.1. Relationship Between TBS and the Cerebellum 
 
To our knowledge this is the first study using 30Hz TBS over the cerebellum to 
modify excitability of the contralateral motor cortex, and the first study to 
demonstrate the effects of cerebellar TBS on TEP. On the one hand it has shown that 
cTBS reduces overall excitability in the motor cortex as measured by MEP amplitude. 
On the other hand iTBS appears to increase intracortical inhibitory mechanisms, but 
without an overall change in MEP amplitude presumably because facilitatory 
networks were also activated. Although these results require replication, they provide 
a better understanding of TBS protocols that could be used therapeutically to treat 
epilepsy and other neurological conditions through modulation of the cerebello-
thalamo-cortical pathway.  
 
5.2. Future Research  
	  
Further studies are required to explore the effects of cerebellar TBS. A larger sample 
size and the use of paired pulse stimulation is required to examine whether the effects 
are due to increased inhibition or decreased excitation. Future studies should also 
explore the duration and time course of the effects. TBS protocols could be then 
applied to patients with dystonia or epilepsy where cortical excitability is altered.   
Although studies in healthy volunteers help to understand the effects of TBS, 
ultimately therapeutic use of TBS in these disorders will depend on the demonstration 








Continuous TBS 80% Pre 80% Post  90% Pre 90% Post 
RMT (% MSO) 73.3 +/- 9.0  74.4 +/- 9.2 65.5 +/- 6.3 66.9 +/- 6.9 
AMT (% MSO) 48.4 +/- 4.7 47.1 +/- 6.3 43.4 +/- 4.7 44.4 +/- 5.4 
 RL (ms) 24.2 +/- 1.8 24.7 +/- 2.3 25.8 +/- 2.0 25.8 +/- 2.8 
 AL (ms) 20.8 +/- 1.6 20.6 +/- 2.1 22.3 +/- 1.6 22.6 +/- 1.9 
 RAMP (mV) 978.3 +/- 899.3 868.2 +/- 498.3 935.5 +/- 326.8 902.4 +/- 313.7 
 AAMP (mV) 5600.6 +/- 3623.0 6072.2+/-3136.1 7278.9 2692.9 7311.3+/- 2830.8 
 CSP (ms) 176.5 +/- 40.1 188.7 +/- 35.4 169.8 +/- 33.5 161.4 +/- 43.8 
 
 
Intermittent TBS 80% Pre 80% Post  90% Pre 90% Post  
RMT (% MSO) 74.6 +/- 10.2 71 +/- 8.4 68.3 +/- 7.1 65.6 +/- 6.4 
 AMT (% MSO) 49 +/- 4.7 46.3 +/- 3.9 41.7 +/- 3.1 42.7 +/- 8.2 
 RL (ms) 24.2 +/- 1.5 24.3 +/- 1.9 25.1 +/- 2.7 24.4 +/- 1.7 
 AL (ms) 20.7 +/- 1.6 21.0 +/- 1.4 21.2 +/- 1.6 21.8 +/- 1.9 
 RAMP (mV) 1328.3 +/- 592.4 1013.7 +/- 363.4 1486.2 +/- 954.1 2025.7+/- 1310.1 
 AAMP (mV) 7926.3 +/- 4919.5 5977.2+/-2370.2 8730.2+/- 2951.8 9199.5+/- 2781.3 
 CSP (ms) 185.5 +/- 39.6 174.3 +/- 47.1 168.6 +/- 25.5 186.8 +/- 33.0 
 
 
SHAM 80% Pre 80% Post  90% Pre 90% Post  
RMT (% MSO) 78.1 +/- 12.6 74.1 +/- 12.8 68.4 +/- 8.2 67.6 +/- 8.5 
 AMT (% MSO) 46.9 +/- 5.6 47.7 +/- 4.4 44.3 +/- 4.9 45.1 +/- 6.9 
 RL (ms) 24.3 +/- 1.5 24.1 +/- 1.3 25.0 +/- 1.8 25.2 +/- 1.8 
 AL (ms) 20.9 +/- 2.0 20.1 +/- 1.6 21.7 +/- 2.1 21.7 +/- 2.5 
 RAMP (mV) 857.5 +/- 475.1 1005.7 +/- 683.3 1058.1 +/- 425.8 1682.3 +/- 871.7 
 AAMP (mV) 7524.7 +/- 8578.7 5110.3+/-1064.0 8095.9+/- 1779.7 7719.2+/- 1599.5 
 CSP (ms) 173.8 +/- 40.4 203.8 +/- 28.5 160.5 +/- 44.3 159.4 +/- 36.1 
 
Appendix.1. Motor evoked potential parameters before and after Theta Burst 
Stimulation.  Mean values and standard deviation are shown for cTBS, iTBS and Sham at 
80% and 90% stimulation. RMT = Resting Motor Threshold, AMT = Active Motor 
Threshold, AL = Active Latency, RL = Resting Latency, RAMP = Resting Motor Evoked 
Potential Amplitude, AAMP = Active Motor Evoked Potential Amplitude, CSP = Cortical 
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